Detection of Vascular Reactive Oxygen Species in Experimental Atherosclerosis by High-Resolution Near-Infrared Fluorescence Imaging Using VCAM-1-Targeted Liposomes Entrapping a Fluorogenic Redox-Sensitive Probe.


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2021
Historique:
received: 26 11 2020
revised: 28 01 2021
accepted: 05 02 2021
entrez: 25 3 2021
pubmed: 26 3 2021
medline: 20 5 2021
Statut: epublish

Résumé

Excessive production of reactive oxygen species (ROS) and the ensuing oxidative stress are instrumental in all phases of atherosclerosis. Despite the major achievements in understanding the regulatory pathways and molecular sources of ROS in the vasculature, the specific detection and quantification of ROS in experimental models of disease remain a challenge. We aimed to develop a reliable and straightforward imaging procedure to interrogate the ROS overproduction in the vasculature and in various organs/tissues in atherosclerosis. To this purpose, the cell-impermeant ROS Brite™ 700 (RB700) probe that produces bright near-infrared fluorescence upon ROS oxidation was encapsulated into VCAM-1-targeted, sterically stabilized liposomes (VLp). Cultured human endothelial cells (EC) and macrophages (Mac) were used for

Identifiants

pubmed: 33763173
doi: 10.1155/2021/6685612
pmc: PMC7963910
doi:

Substances chimiques

Apolipoproteins E 0
Fenton's reagent 0
Fluorescent Dyes 0
Liposomes 0
Reactive Oxygen Species 0
Vascular Cell Adhesion Molecule-1 0
3-nitrotyrosine 3604-79-3
Tyrosine 42HK56048U
Hydrogen Peroxide BBX060AN9V
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6685612

Informations de copyright

Copyright © 2021 Simona-Adriana Manea et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Circulation. 2002 Mar 26;105(12):1429-35
pubmed: 11914250
Antioxid Redox Signal. 2016 Jun 1;24(16):939-58
pubmed: 27139586
JACC Basic Transl Sci. 2018 May 30;3(3):378-390
pubmed: 30062224
Redox Biol. 2016 Aug;8:226-42
pubmed: 26827126
Antioxid Redox Signal. 2018 Aug 20;29(6):585-602
pubmed: 29054131
Arterioscler Thromb. 1993 Feb;13(2):197-204
pubmed: 7678986
Pharm Res. 2005 Nov;22(11):1906-17
pubmed: 16088429
Kidney Int. 2005 May;67(5):1662-4
pubmed: 15840007
Antioxid Redox Signal. 2016 May 1;24(13):731-51
pubmed: 26607375
Pharmaceutics. 2019 Jan 21;11(1):
pubmed: 30669699
Cell Tissue Res. 2010 Dec;342(3):325-39
pubmed: 21052718
Atherosclerosis. 2012 Sep;224(1):25-36
pubmed: 22682779
Antioxid Redox Signal. 2019 Apr 1;30(10):1369-1386
pubmed: 29132214
Curr Med Chem. 2017;24(6):550-567
pubmed: 27881067
Transl Vis Sci Technol. 2019 Nov 20;8(6):20
pubmed: 31788349
Eur J Pharm Biopharm. 2015 Jan;89:18-29
pubmed: 25438248
Antioxid Redox Signal. 2018 May 20;28(15):1416-1432
pubmed: 29037049
Methods Mol Biol. 2019;1990:85-91
pubmed: 31148064
Anal Chem. 2020 Jun 16;92(12):8010-8014
pubmed: 32441506
Ann Biomed Eng. 2012 Sep;40(9):2059-68
pubmed: 22562306
Biochem Biophys Res Commun. 2015 May 22;461(1):172-9
pubmed: 25871798
Circ Res. 2018 Jul 20;123(3):326-328
pubmed: 30026378
Antioxid Redox Signal. 2014 Jan 10;20(2):372-82
pubmed: 22978713
Vet Parasitol. 2018 May 15;255:78-82
pubmed: 29773141
Arterioscler Thromb. 1994 Jan;14(1):133-40
pubmed: 8274468
Front Biosci (Schol Ed). 2012 Jan 01;4:651-70
pubmed: 22202083
Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5862-70
pubmed: 26348635
Mol Imaging Biol. 2006 Jul-Aug;8(4):201-7
pubmed: 16791746
Redox Biol. 2018 Jun;16:332-343
pubmed: 29587244
Gastroenterology. 2015 Jul;149(1):177-189.e10
pubmed: 25797700
Redox Biol. 2019 Feb;21:101071
pubmed: 30576927
Biomed Res Int. 2020 May 18;2020:1753152
pubmed: 32509849
Methods. 2016 Oct 15;109:3-11
pubmed: 27302663
Redox Biol. 2020 Jan;28:101338
pubmed: 31634818
Antioxid Redox Signal. 2018 Aug 20;29(6):569-584
pubmed: 29566558
Mucosal Immunol. 2016 Nov;9(6):1500-1513
pubmed: 26982596
Oxid Med Cell Longev. 2019 Sep 2;2019:3201062
pubmed: 31565149
Curr Opin Chem Biol. 2010 Feb;14(1):43-9
pubmed: 19926519
Plant J. 2012 Apr;70(1):118-28
pubmed: 22449047
Cell Metab. 2020 Mar 3;31(3):642-653.e6
pubmed: 32130885
Biochim Biophys Acta. 2014 Feb;1840(2):730-8
pubmed: 23665586
Free Radic Biol Med. 2007 Oct 1;43(7):995-1022
pubmed: 17761297

Auteurs

Simona-Adriana Manea (SA)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Mihaela-Loredana Vlad (ML)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Daniela Rebleanu (D)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Alexandra-Gela Lazar (AG)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Ioana Madalina Fenyo (IM)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Manuela Calin (M)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Maya Simionescu (M)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Adrian Manea (A)

Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, Bucharest, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH